20 min listen
Cannabinoids’ Affect on Human Microbiomes with Pam Miles and Cindy Orser, PhD
Cannabinoids’ Affect on Human Microbiomes with Pam Miles and Cindy Orser, PhD
ratings:
Length:
20 minutes
Released:
Sep 28, 2022
Format:
Podcast episode
Description
Pam Miles is the CEO and founder of Apothercare, a company that partners with scientists performing women's health research. Cindy Orser, PhD is currently Chief Scientific Officer at CLIP LABS, a cannabis testing laboratory in California, and she has more than 25 years of experience innovating technologies related to cannabis, human diagnostics, and even detecting biothreat agents. Cindy is also a member of the CannMed 23 Advisory Board, and she has been a panelist at several past CannMed events.
As you will hear in the interview, Pam and Cindy met at CannMed 2019, which is great example of how attending a CannMed event can lead to important professional partnerships. We talked about the work Pam and Cindy have done to understand how cannabis affects the human microbiome, specifically the vaginal microbiome. Other topics include:
Why a healthy reproductive microbiome is important for women's health The antimicrobial activity of cannabinoidsThe lack of safety testing around women’s health products How cannabinoids affect the gut microbiome How bacteria communicate with the human body and affect mental health
Thanks to This Episode’s Sponsor: Medicine Women Health
Medicine Women’s team of specialists includes Medical Doctors, Naturopaths, Medical Cannabis Experts, Nutritionists and Alternative Health Practitioners. These integrative teams evaluate health issues and design targeted protocols to promote personal healing. Medicine Women’s Protocols have successfully alleviated symptoms of Cancer, Auto-Immune Diseases and Neurological Conditions, as well as providing overall Health Rejuvenation.
Learn more at www.medicinewomenhealth.com.
Additional Resources
Intimate Care Products with Cannabinoids Need More Safety Data [Cannabis Industry Journal]Apothercare websiteSubmit an Abstract for CannMed 23Review the Podcast!CannMed ArchiveCannMed Community Board [Facebook Group]Healthcare Provider Medical Cannabis Research Study
As you will hear in the interview, Pam and Cindy met at CannMed 2019, which is great example of how attending a CannMed event can lead to important professional partnerships. We talked about the work Pam and Cindy have done to understand how cannabis affects the human microbiome, specifically the vaginal microbiome. Other topics include:
Why a healthy reproductive microbiome is important for women's health The antimicrobial activity of cannabinoidsThe lack of safety testing around women’s health products How cannabinoids affect the gut microbiome How bacteria communicate with the human body and affect mental health
Thanks to This Episode’s Sponsor: Medicine Women Health
Medicine Women’s team of specialists includes Medical Doctors, Naturopaths, Medical Cannabis Experts, Nutritionists and Alternative Health Practitioners. These integrative teams evaluate health issues and design targeted protocols to promote personal healing. Medicine Women’s Protocols have successfully alleviated symptoms of Cancer, Auto-Immune Diseases and Neurological Conditions, as well as providing overall Health Rejuvenation.
Learn more at www.medicinewomenhealth.com.
Additional Resources
Intimate Care Products with Cannabinoids Need More Safety Data [Cannabis Industry Journal]Apothercare websiteSubmit an Abstract for CannMed 23Review the Podcast!CannMed ArchiveCannMed Community Board [Facebook Group]Healthcare Provider Medical Cannabis Research Study
Released:
Sep 28, 2022
Format:
Podcast episode
Titles in the series (97)
Testing Cannabis Products with Ini Afia: In this episode we get the chance to talk with our first representative from the Safety Focus Area. Ini Afia is the Scientific Director at CannaSafe Labs, one of the largest cannabis testing labs in California. by CannMed Coffee Talk